Economic Survey data fuels hopes of good budget
Economic Survey data fuels hopes of good budget

Economic Survey data fuels hopes of good budget

Gayathri Udyawar Article rating: 3.0

The Economic Survey tabled by the government as part of the pre-budget session buoyed the market throughout the trading session on Monday. The stock markets traded near their all-time high in a rangebound manner. The survey reported that more than 60 per cent of India's GDP is fueled by internal trade.

SME IPO of Sintercom India to open on Feb 5
SME IPO of Sintercom India to open on Feb 5

SME IPO of Sintercom India to open on Feb 5

Tanay Loya Article rating: 4.3

Sintercom India Limited on Monday announced the launch of its NSE Emerge SME initial public offer (IPO). The issue is scheduled to be open for subscription between February 5 to 7, 2018 with a price band of Rs. 63 to Rs. 65 per equity share of face value of Rs. 10 each.

KSB Pumps shines backed by NPCIL orders
KSB Pumps shines backed by NPCIL orders

KSB Pumps shines backed by NPCIL orders

Nidhi Jani Article rating: 5.0

KSB Pumps has received orders of around Rs. 413 crores from Nuclear Power Corporation of India Limited (NPCIL). The orders are for supply of primary coolant pumps and electric motor along with auxiliaries and accessories for NPCIL's Gorakhpur Haryana Anu Vidyut Pariyojana – 1 & 2.

Ten stocks close to their 52-week high
Ten stocks close to their 52-week high

Ten stocks close to their 52-week high

Shital Jibhe Article rating: 5.0

The markets on January 29 opened gap up. BSE Sensex is trading at 36,366.88, up by 316.44 points and the Nifty is trading at 11,152.45, up by 82.80 points. 

Newgen Software debuts at 3.3 per cent premium
Newgen Software debuts at 3.3 per cent premium

Newgen Software debuts at 3.3 per cent premium

Tanay Loya Article rating: 5.0

Newgen Software Technologies listed at Rs. 253 on BSE, at a premium of 3.3 per cent on its issue price of Rs. 245 per share after the company received a good response to its IPO offer.

Cipla receives final approval for generic anti-HIV drug
Cipla receives final approval for generic anti-HIV drug

Cipla receives final approval for generic anti-HIV drug

Gayathri Udyawar Article rating: 4.0

Global pharma major Cipla has received final approval from USFDA to market a generic equivalent of Tenofovir Disoproxil Fumarate 300mg tablets. The drug will be made available for commercial shipment in the US immediately. 

Five stocks with selling interest
Five stocks with selling interest

Five stocks with selling interest

Shital Jibhe Article rating: 3.0

Overall volumes in futures & options currently stand at 1.88 crore contracts with a turnover of Rs. 17,50,208.42 crore.

Five stocks with buying interest
Five stocks with buying interest

Five stocks with buying interest

Shital Jibhe Article rating: No rating

Overall volumes in futures & options currently stand at 1.88 crore contracts with a turnover of Rs. 17,50,208.42 crore.

Index trend and stocks in action January 29, 2018
Index trend and stocks in action January 29, 2018

Index trend and stocks in action January 29, 2018

Karan Dsij Article rating: 5.0

Going forward, important support for the Nifty is placed around the level of 10,990, but if Nifty fails to hold this support level, then a correction is expected up to the levels of 10,930-10,900. On the upside, the high of 11,110 might act as immediate resistance for the Nifty, followed by 11,200. Top stocks to watch out: FIEM Industries, Vakrangee, Jagran Prakashan, Havells, FDC, Hind Copper, Capital First, Kokuyo Camlin, Prataap Snacks, Amrutanjan Healthcare, Bharat Forge, and Reliance Industries. 

RSS
First30983099310031013103310531063107Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR